Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity

por Fritah, Hajer, Graciotti, Michele, Lai-Lai Chiang, Cheryl, Huguenin- Bergenat, Anne-Laure, Petremand, Rémy, Ahmed, Ritaparna, Guillaume, Philippe, Schmidt, Julien, Stevenson, Brian J., Gfeller, David, Harari, Alexandre, Kandalaft, Lana E.
Publicado 2023